Pregnancy and amyloidosis: II. Suppression of amyloidogenesis during pregnancy

Shmuel Shtrasburg*, Mordechai Pras, Mordechai Dolitzky, Clara Pariente, Rivka Gal, Avi Livneh

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

The observation of a deleterious effect of pregnancy on kidney function in amyloidosis of familial Mediterranean fever suggests that pregnancy may enhance amyloidogenesis. To determine whether pregnancy may indeed affect amyloidogenesis, pregnant mice were made amyloidotic by administration of amyloid-enhancing factor (AEF) and AgNO3 at different points in time from conception, and amyloid- deposition was studied with the crush-and-smear technique. A possible effect of exogenous female sex hormones (β-estradiol and progesterone) on amyloidogenesis was studied by administration of these hormones during amyloid induction in nonpregnant female mice. Amyloidogenesis was found to be significantly suppressed in mice during pregnancy. The reduction was possibly related to the effect of pregnancy on the inflammatory stimulus (AgNO3) and not on the administered AEF. Exogenous estrogen and progesterone failed to inhibit amyloidogenesis in nonpregnant mice. These findings suggest that pregnancy may suppress amyloidogenesis in mice. The suppression is caused by an anti-inflammatory effect of pregnancy. Estrogen and progesterone are probably unrelated to this finding.

Original languageEnglish
Pages (from-to)314-319
Number of pages6
JournalJournal of Laboratory and Clinical Medicine
Volume136
Issue number4
DOIs
StatePublished - 2000

Fingerprint

Dive into the research topics of 'Pregnancy and amyloidosis: II. Suppression of amyloidogenesis during pregnancy'. Together they form a unique fingerprint.

Cite this